Recombinant Human LITAF Protein，His

LITAF, or Lipopolysaccharide-Induced TNF-alpha Factor, is a protein that plays a significant role in the immune response and inflammation. It was initially identified as a transcription factor involved in the regulation of pro-inflammatory cytokines, particularly tumor necrosis factor-alpha (TNF-α), in response to lipopolysaccharide (LPS) stimulation, which mimics bacterial infection. The study of LITAF has gained importance due to its implications in various diseases, including autoimmune disorders, chronic inflammatory diseases, and certain cancers. Researchers have focused on the structural and functional characterization of LITAF to understand its mechanism of action and interactions with other cellular pathways. Notably, the LITAF protein has been linked to the regulation of gene expression in response to inflammatory stimuli, making it a potential therapeutic target. Additionally, studies have revealed that mutations in the LITAF gene can lead to disease, underscoring its role in human health. The reconstitution of LITAF as a recombinant protein has enabled detailed investigations into its function, binding partners, and the downstream signaling pathways it influences. This research is crucial for developing novel therapies aimed at modulating LITAF's activity to treat various inflammatory conditions effectively. Understanding LITAF's structure and function could pave the way for innovative strategies in managing inflammation-related diseases, enhancing our ability to design targeted interventions for improving patient outcomes.